Epilepsy is the most general, extensive, and severe neurological disorder, affecting more than 50 million individuals globally. Initially, conventional medicines and simple salts like potassium bromide were employed as antiepileptic medication candidates. Nowadays, many anticonvulsant drugs have been discovered as first-generation and second-generation and newer drugs and are still in development phases. The pharmacophore-based drug design process includes pharmacophore modeling and validation, pharmacophore-based virtual screening, virtual hits profiling, and lead identification with special reference. This comprehensive article reviews recently developed anticonvulsant derivatives on the basis of pharmacophoric approaches. A literature survey was performed using various search engines like Google Scholar, Scopus, Sci Finder, ScienceDirect, Science gate, Scilit, PubMed, NINDS database of NIH, Bentham Sciences, and other online and print journals and scientific databases. The presented review discusses such kinds of newer drugs that are in the market as well as in clinical trial phases. Detailed outcomes of pharmacophoric modeling have been discussed for newly derived derivatives like targets involved in Epilepsy, lead molecules etc., for the treatment of epilepsy. This exhaustive review will assist the researchers in the further development of potential antiepileptic agents.
Keyphrases
- clinical trial
- molecular docking
- molecular dynamics
- drug induced
- adverse drug
- healthcare
- public health
- spinal cord injury
- cross sectional
- social media
- risk assessment
- smoking cessation
- early onset
- single cell
- machine learning
- health information
- adipose tissue
- human health
- subarachnoid hemorrhage
- deep learning
- brain injury
- combination therapy
- molecular dynamics simulations
- electronic health record
- artificial intelligence
- cerebral ischemia